Form 8-K - Current report:
SEC Accession No. 0001490978-25-000026
Filing Date
2025-03-10
Accepted
2025-03-10 08:32:04
Documents
13
Period of Report
2025-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20250307.htm   iXBRL 8-K 28069
  Complete submission text file 0001490978-25-000026.txt   156113

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20250307.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20250307_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20250307_pre.xml EX-101.PRE 13054
16 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20250307_htm.xml XML 3223
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 25722283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)